Coronal Mode Ultrasound Guided Hemodialysis Cannulation: A Pilot Randomized Comparison With Standard Cannulation Technique
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Arteriovenous Fistula, Cannulation
- Sponsor
- Henry Ford Health System
- Enrollment
- 10
- Locations
- 1
- Primary Endpoint
- Infiltration Due to Dialysis Access Cannulation
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Infiltrations from cannulation difficulties result in significant morbidity including loss of vascular access (VA) loss in hemodialysis (HD). Cannulation is reliant on personnel skill and VA characteristics. Surface marking of VA lacks real-time information and traditional ultrasound (US) devices are large, expensive and require skilled operator expertise. Sonic Window© (Analogic Ultrasound, Peabody, MA) is a coronal mode ultrasound device (CMUD) approved for VA cannulation. Study is a single center randomized, prospective pilot study comparing handheld US-guided cannulation of new arteriovenous fistula (AVF) to standard cannulation practices.
Investigators
Lalathaksha Kumbar
Senior staff Physician
Henry Ford Health System
Eligibility Criteria
Inclusion Criteria
- •End-stage renal disease with new arteriovenous fistula being started for cannulation
Exclusion Criteria
- •End-stage renal disease with grafts
Outcomes
Primary Outcomes
Infiltration Due to Dialysis Access Cannulation
Time Frame: 3 weeks from use of fistula
Infiltration is the extravasation of blood from fistula due to problems with needle insertion into fistula for dialysis.
Secondary Outcomes
- Patient Pain Scale(3 weeks from use of fistula)